India, July 20 -- Beginning in August 2026, this healthcare company focused on central nervous system (CNS) cancers will adopt a new name, following months of planning that reflect its evolution into an integrated CNS oncology platform.
The company we are profiling today is Plus Therapeutics Inc. (PSTV), which will officially rebrand as Cerenome and begin trading under the new ticker symbol CNSY, effective August 3, 2026.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....